FeesSafety
Pluang+

Law firm investigates Evolus over FDA warning on misleading Jeuveau promotion

Market News
11 Nov 2026, 00:40 WIB
GlobeNewsWire
View Source
Bearish
Law firm investigates Evolus over FDA warning on misleading Jeuveau promotion

Pomerantz LLP is investigating Evolus, Inc. following an FDA warning about misleading Instagram promotions for its wrinkle treatment Jeuveau. The FDA criticized the promotion for downplaying safety risks and making exaggerated claims about the product's effectiveness. After the warning was disclosed on October 2, 2026, Evolus's stock dropped over 7%. The investigation will determine if Evolus or its executives engaged in securities fraud or unlawful practices, potentially leading to a class action lawsuit by investors.

Regarding Evolus, Inc., here is Pluang's health sector market snapshot as of Nov 11, 2026 04:52 WIB: Out of 150 priced health-sector US stocks, 49 rose and 100 fell today. Notable movers include CTXR at USD 0.49 with a 1-day change of -7.51% and a Pluang order activity of 1% Sell / 99% Buy, TLRY at USD 2.65 down 7.02%, and LQDA at USD 51.13 up 6.81%.

More News

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...

Company Fundamentals
Bullish
1 hour ago
Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...

Others
Bullish
1 hour ago
TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...

Company Fundamentals
Bullish
1 hour ago
Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...

Company Fundamentals
Neutral
3 hours ago
Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App